Biosimilars
-
{
- All
- News
-
India's Cancer Affordability: Cheaper Drugs Alone Cannot Save More Lives
- Monday November 2, 2026
- Health | Written by Dr Prashant Mehta
Price control is not the answer to India's cancer problem. What it needs is a comprehensive strategy of transparent pharmaceutical pricing, indigenous innovation, rational treatment protocols, evidence-based reimbursement and equitable health care delivery.
-
www.ndtv.com/health
-
Are All Versions Of Semaglutide The Same? Doctor Answers
- Sunday October 4, 2026
- Health | Written by Dr Ritesh Agarwal
The original semaglutide was studied extensively in 50+ large-scale clinical trials and real-world settings, and has gathered 58 million patient years of exposure, providing insights into its long-term safety and efficacy, including effects on cardiovascular and metabolic health.
-
www.ndtv.com/health
-
India To Lead Global Pharma Landscape With Innovation-Driven Approach: Minister
- Monday April 13, 2026
- Health | Indo Asian Service News
India aims to lead global pharma with focus on biologics, biosimilars, and specialty medicines, says Health Minister JP Nadda.
-
www.ndtv.com/health
-
India To Lead Global Pharma Landscape With Innovation-Driven Approach: Minister
- Monday April 13, 2026
- Health | Indo Asian News Service
India aims to lead global pharma with focus on biologics, biosimilars, and specialty medicines, says Health Minister JP Nadda.
-
www.ndtv.com/health
-
Deals, Drugs, And Disruption: Glenmark, Lupin, IPCA Labs And Others Lead India's Pharma Opportunity Boom
- Thursday September 25, 2025
- Author: Varsha Chandnani
The pharmaceutical sector has seen a flurry of new deals, partnerships, and drug launches this week, presenting potential significant growth opportunities in oncology, biosimilars, and diabetes care.
-
www.ndtvprofit.com
-
Aurobindo Pharma's Subsidiary Receives GMP From European Medicines Agency For Biosimilars Facility
- Tuesday November 12, 2024
- Author: Prajwal Jayaraj
CuraTeQ Biologics' EMA GMP certification marks a key milestone in Aurobindo Pharma's expansion into biosimilars, with three products under review for European approval in oncology and immunology.
-
www.ndtvprofit.com
-
Epirus, Ranbaxy Win India Approval for Arthritis Drug Copy
- Thursday December 7, 2023
- Author: NDTV Profit Desk
The market for copycat biotech drugs, known as biosimilars, is becoming more lucrative as patents expire on older, high-priced antibody drugs that rank among the pharmaceutical industry's biggest sellers.
-
www.ndtvprofit.com
-
Biocon's Breast Cancer Biosimilar Gets USFDA Panel Nod, Shares Surge
- Thursday December 7, 2023
- Author: Press Trust of India
In a regulatory filing, Biocon said the committee voted 16-0 in support of eligible indications of the reference product.
-
www.ndtvprofit.com
-
India's Cancer Affordability: Cheaper Drugs Alone Cannot Save More Lives
- Monday November 2, 2026
- Health | Written by Dr Prashant Mehta
Price control is not the answer to India's cancer problem. What it needs is a comprehensive strategy of transparent pharmaceutical pricing, indigenous innovation, rational treatment protocols, evidence-based reimbursement and equitable health care delivery.
-
www.ndtv.com/health
-
Are All Versions Of Semaglutide The Same? Doctor Answers
- Sunday October 4, 2026
- Health | Written by Dr Ritesh Agarwal
The original semaglutide was studied extensively in 50+ large-scale clinical trials and real-world settings, and has gathered 58 million patient years of exposure, providing insights into its long-term safety and efficacy, including effects on cardiovascular and metabolic health.
-
www.ndtv.com/health
-
India To Lead Global Pharma Landscape With Innovation-Driven Approach: Minister
- Monday April 13, 2026
- Health | Indo Asian Service News
India aims to lead global pharma with focus on biologics, biosimilars, and specialty medicines, says Health Minister JP Nadda.
-
www.ndtv.com/health
-
India To Lead Global Pharma Landscape With Innovation-Driven Approach: Minister
- Monday April 13, 2026
- Health | Indo Asian News Service
India aims to lead global pharma with focus on biologics, biosimilars, and specialty medicines, says Health Minister JP Nadda.
-
www.ndtv.com/health
-
Deals, Drugs, And Disruption: Glenmark, Lupin, IPCA Labs And Others Lead India's Pharma Opportunity Boom
- Thursday September 25, 2025
- Author: Varsha Chandnani
The pharmaceutical sector has seen a flurry of new deals, partnerships, and drug launches this week, presenting potential significant growth opportunities in oncology, biosimilars, and diabetes care.
-
www.ndtvprofit.com
-
Aurobindo Pharma's Subsidiary Receives GMP From European Medicines Agency For Biosimilars Facility
- Tuesday November 12, 2024
- Author: Prajwal Jayaraj
CuraTeQ Biologics' EMA GMP certification marks a key milestone in Aurobindo Pharma's expansion into biosimilars, with three products under review for European approval in oncology and immunology.
-
www.ndtvprofit.com
-
Epirus, Ranbaxy Win India Approval for Arthritis Drug Copy
- Thursday December 7, 2023
- Author: NDTV Profit Desk
The market for copycat biotech drugs, known as biosimilars, is becoming more lucrative as patents expire on older, high-priced antibody drugs that rank among the pharmaceutical industry's biggest sellers.
-
www.ndtvprofit.com
-
Biocon's Breast Cancer Biosimilar Gets USFDA Panel Nod, Shares Surge
- Thursday December 7, 2023
- Author: Press Trust of India
In a regulatory filing, Biocon said the committee voted 16-0 in support of eligible indications of the reference product.
-
www.ndtvprofit.com